SPXX
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest
Advertisement

SPXX Technical Analysis

Summary of all the Indicators

Summary
Strong Buy
16Bullish
5Neutral
1Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest is a Buy.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) 20-Day exponential moving average is 17.55, making it a Buy.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) 50-Day exponential moving average is 17.55, making it a Buy.

Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest (SPXX) Pivot Points

Nov 13, 2025, 07:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.29
17.37
17.44
17.52
17.59
17.67
17.74
Fibonacci
17.37
17.43
17.47
17.52
17.58
17.62
17.67

Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest (SPXX) Moving Averages

Nov 13, 2025, 07:58 AM
Period
Simple
Exponential
MA5
17.53Buy
17.55Buy
MA10
17.61Buy
17.56Buy
MA20
17.55Buy
17.55Buy
MA50
17.61Buy
17.55Buy
MA100
17.58Buy
17.43Buy
MA200
17.01Buy
17.06Buy
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) 10-Day exponential moving average is 17.56, making it a Buy.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) 100-Day exponential moving average is 17.43, making it a Buy.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) 50-day simple moving average is 17.61, creating a Buy signal.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) 100-day simple moving average is 17.58, creating a Buy signal.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) 200-day simple moving average is 17.01, creating a Buy signal.

Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest (SPXX) Technical Analysis

Nov 13, 2025, 07:58 AM
Name
Value
Action
RSI (14)
52.47
Neutral
STOCH (9,6)
44.48
Neutral
STOCHRSI (14)
44.44
Neutral
MACD (12,26)
0.01
Buy
ADX (14)
15.61
Buy
Williams %R
-36.36
Buy
CCI (14)
13.53
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
44.63
Neutral
ROC
1.09
Buy
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) Relative Strength Index (RSI) is 52.47, creating a Neutral signal.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) Trend Strength Indicator (ADX) is 15.61, creating a Buy signal.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) Commodity Channel Index (CCI) is 13.53, creating a Neutral signal.
Nuveen S&P 500 Dynamic Overwrite Fund of Benef Interest’s (SPXX) Price Rate of Change (ROC) is 1.09, creating a Buy signal.

FAQ

Is SPXX a Buy, Hold, or Sell?
Based on SPXX’s technical indicators, SPXX is a Strong Buy.
    What is SPXX’s RSI (14)?
    SPXX’s RSI (14) is 52.47, which suggests SPXX is a Neutral.
      What is SPXX’s MACD?
      SPXX’s MACD is 0.01, which suggests SPXX is a Buy.
        What is SPXX’s 5-day moving average?
        SPXX’s 5-day moving average is 17.53, which suggests SPXX is a Buy.
          What is SPXX’s 20-day moving average?
          SPXX 20-day moving average is 17.55, which suggests SPXX is a Buy.
            What is SPXX’s 50-day moving average?
            SPXX’s 50-day moving average is 17.61, which suggests SPXX is a Buy.
              What is SPXX’s 200-day moving average?
              SPXX’s 200-day moving average is 17.01, which suggests SPXX is a Buy.
                What is SPXX’s Williams % R (14)?
                SPXX’s Williams % R (14) is -36.36, which suggests SPXX is a Buy.
                  What is SPXX’s CCI (14)?
                  SPXX’s CCI (14) is 13.53, which suggests SPXX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement